Survival Benefit of Glioblastoma Patients After FDA Approval of Temozolomide Concomitant With Radiation and Bevacizumab: A Population-Based Study
Oncotarget - United States
doi 10.18632/oncotarget.17054
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 12, 2017
Authors
Publisher
Impact Journals, LLC